共 28 条
[1]
Barnholtz-Sloan J.S., Et al., Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System, J Clin Oncol, 22, 14, pp. 2865-2872, (2004)
[2]
Gavrilovic I.T., Posner J.B., Brain metastases: epidemiology and pathophysiology, J Neurooncol., 75, 1, pp. 5-14, (2005)
[3]
Berghoff A.S., Et al., Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers, ESMO Open, 1, 2, (2016)
[4]
Soffietti R., Et al., Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO), Neuro Oncol., 19, 2, pp. 162-174, (2017)
[5]
Preusser M., Et al., Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012, Eur J Cancer, 48, 18, pp. 3439-3447, (2012)
[6]
Kienast Y., Et al., Real-time imaging reveals the single steps of brain metastasis formation, Nat Med, 16, 1, pp. 116-122, (2010)
[7]
Berghoff A.S., Et al., Invasion patterns in brain metastases of solid cancers, Neuro Oncol., 15, 12, pp. 1664-1672, (2013)
[8]
Berghoff A.S., Et al., Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases, Neuropathol Appl Neurobiol, 41, 2, pp. e41-e55, (2015)
[9]
Ilhan-Mutlu A., Et al., Bevacizumab prevents brain metastases formation in lung adenocarcinoma, Mol Cancer Ther, 15, 4, pp. 702-710, (2016)
[10]
Bohn K.A., Et al., Inhibition of VEGF and angiopoietin-2 to reduce brain metastases of breast cancer burden, Front Pharmacol, 8, (2017)